Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
INBS | US
0.03
1.92%
Healthcare
Medical Devices
30/06/2024
04/10/2024
1.59
1.73
1.73
1.58
Intelligent Bio Solutions Inc. a medical technology company developing non-invasive real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system a revolutionizing portable testing through fingerprint sweat analysis which has the potential for broader applications in additional fields; and biosensor platform for biochemistry immunology tumor markers hormones and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
83.0%1 month
144.9%3 months
108.4%6 months
98.7%-
-
0.93
0.10
0.06
-0.91
0.74
-
-9.31M
6.76M
6.76M
-
-386.32
-
64.20
-171.71
0.11
14.36
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.45
Range1M
1.74
Range3M
2.00
Rel. volume
0.03
Price X volume
255.35K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Nexalin Technology Inc. | NXL | Medical Devices | 0.6579 | 6.96M | 5.45% | n/a | 0.00% |
Sharps Technology Inc. | STSS | Medical Instruments & Supplies | 0.1524 | 4.36M | -0.78% | n/a | 0.00% |
Predictive Oncology Inc | POAI | Medical Instruments & Supplies | 0.6434 | 4.29M | -11.63% | n/a | 65.94% |
Acutus Medical Inc | AFIB | Medical Devices | 0.122 | 3.65M | 45.24% | n/a | -745.93% |
Common Stock | VERO | Medical Devices | 0.4488 | 3.26M | -12.00% | n/a | 1351.51% |
Talis Biomedical Corporation Common Stock | TLIS | Medical Devices | 1.78 | 3.24M | -6.32% | n/a | 38.66% |
INVO Bioscience Inc | INVO | Medical Devices | 0.7 | 2.73M | 3.55% | 1.03 | 394.32% |
ThermoGenesis Holdings Inc | THMO | Medical Devices | 0.16 | 2.54M | 1.20% | n/a | 776.10% |
NUWE | NUWE | Medical Devices | 1.32 | 2.46M | -10.81% | n/a | -9.57% |
Sintx Technologies Inc | SINT | Medical Devices | 3.23 | 2.41M | 0.94% | n/a | 47.07% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ALBT | ALBT | Real Estate Services | 0.2137 | 3.42M | 6.85% | n/a | 187.39% |
DigitalBridge Group Inc. | DBRG-PJ | Real Estate Services | 25.2 | 0 | 0.20% | n/a | 17.23% |
DigitalBridge Group Inc. | DBRG-PI | Real Estate Services | 25.45 | 0 | 0.24% | n/a | 17.23% |
DigitalBridge Group Inc. | DBRG-PH | Real Estate Services | 25.35 | 0 | 0.00% | n/a | 17.23% |
Common Stock | BPYPO | Real Estate Services | 16.78 | 0 | 0.54% | 7.55 | 866.10% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.91 | 45.99 | Cheaper |
Ent. to Revenue | 0.74 | 13.20 | Cheaper |
PE Ratio | - | 29.98 | - |
Price to Book | 0.93 | 6.06 | Cheaper |
Dividend Yield | - | 1.65 | - |
Std. Deviation (3M) | 108.38 | 66.08 | Riskier |
Debt to Equity | 0.10 | 0.83 | Cheaper |
Debt to Assets | 0.06 | 0.28 | Cheaper |
Market Cap | 6.76M | 9.42B | Emerging |